A New Lease on Life for an HIV-neutralizing Antibody Class and Vaccine Target

Overview

Journal Proc Natl Acad Sci U S A

Specialty Science

Date 2021 Jan 28

PMID 33504595

Citations 4

Authors

Dennis R Burton

Affiliations

Soon will be listed here.

Citing Articles

HIV-1 prehairpin intermediate inhibitors show efficacy independent of neutralization tier.

Bell B, Bruun T, Friedland N, Kim P Proc Natl Acad Sci U S A. 2023; 120(8):e2215792120.

PMID: 36795752 PMC: 9974412. DOI: 10.1073/pnas.2215792120.

A human antibody reveals a conserved site on beta-coronavirus spike proteins and confers protection against SARS-CoV-2 infection.

Zhou P, Yuan M, Song G, Beutler N, Shaabani N, Huang D Sci Transl Med. 2022; 14(637):eabi9215.

PMID: 35133175 PMC: 8939767. DOI: 10.1126/scitranslmed.abi9215.

A Derivative of the D5 Monoclonal Antibody That Targets the gp41 N-Heptad Repeat of HIV-1 with Broad Tier-2-Neutralizing Activity.

Rubio A, Filsinger Interrante M, Bell B, Brown C, Bruun T, LaBranche C J Virol. 2021; 95(15):e0235020.

PMID: 33980592 PMC: 8274607. DOI: 10.1128/JVI.02350-20.

A human antibody reveals a conserved site on beta-coronavirus spike proteins and confers protection against SARS-CoV-2 infection.

Zhou P, Yuan M, Song G, Beutler N, Shaabani N, Huang D bioRxiv. 2021; .

PMID: 33821273 PMC: 8020973. DOI: 10.1101/2021.03.30.437769.

References

Miller M, Geleziunas R, Bianchi E, Lennard S, Hrin R, Zhang H . A human monoclonal antibody neutralizes diverse HIV-1 isolates by binding a critical gp41 epitope. Proc Natl Acad Sci U S A. 2005; 102(41):14759-64. PMC: 1253587. DOI: 10.1073/pnas.0506927102. View

Montefiori D, Filsinger Interrante M, Bell B, Rubio A, Joyce J, Shiver J . The high-affinity immunoglobulin receptor FcγRI potentiates HIV-1 neutralization via antibodies against the gp41 N-heptad repeat. Proc Natl Acad Sci U S A. 2021; 118(3). PMC: 7826338. DOI: 10.1073/pnas.2018027118. View

Pegu A, Borate B, Huang Y, Pauthner M, Hessell A, Julg B . A Meta-analysis of Passive Immunization Studies Shows that Serum-Neutralizing Antibody Titer Associates with Protection against SHIV Challenge. Cell Host Microbe. 2019; 26(3):336-346.e3. PMC: 6755677. DOI: 10.1016/j.chom.2019.08.014. View

Labonte J, Lebbos J, Kirkpatrick P . Enfuvirtide. Nat Rev Drug Discov. 2003; 2(5):345-6. DOI: 10.1038/nrd1091. View

Lore K, Smed-Sorensen A, Vasudevan J, Mascola J, Koup R . Myeloid and plasmacytoid dendritic cells transfer HIV-1 preferentially to antigen-specific CD4+ T cells. J Exp Med. 2005; 201(12):2023-33. PMC: 2212038. DOI: 10.1084/jem.20042413. View

Chan D, Kim P . HIV entry and its inhibition. Cell. 1998; 93(5):681-4. DOI: 10.1016/s0092-8674(00)81430-0. View

Burton D . Antibody barriers to going viral. J Exp Med. 2019; 216(10):2226-2228. PMC: 6781000. DOI: 10.1084/jem.20191099. View

Rubio A, Filsinger Interrante M, Bell B, Brown C, Bruun T, LaBranche C . A Derivative of the D5 Monoclonal Antibody That Targets the gp41 N-Heptad Repeat of HIV-1 with Broad Tier-2-Neutralizing Activity. J Virol. 2021; 95(15):e0235020. PMC: 8274607. DOI: 10.1128/JVI.02350-20. View

Eckert D, Kim P . Mechanisms of viral membrane fusion and its inhibition. Annu Rev Biochem. 2001; 70:777-810. DOI: 10.1146/annurev.biochem.70.1.777. View

10.

Klasse P . Neutralization of Virus Infectivity by Antibodies: Old Problems in New Perspectives. Adv Biol. 2016; 2014. PMC: 4835181. DOI: 10.1155/2014/157895. View

11.

Holl V, Peressin M, Schmidt S, Decoville T, Zolla-Pazner S, Aubertin A . Efficient inhibition of HIV-1 replication in human immature monocyte-derived dendritic cells by purified anti-HIV-1 IgG without induction of maturation. Blood. 2006; 107(11):4466-74. PMC: 1895798. DOI: 10.1182/blood-2005-08-3490. View

12.

Holl V, Peressin M, Decoville T, Schmidt S, Zolla-Pazner S, Aubertin A . Nonneutralizing antibodies are able to inhibit human immunodeficiency virus type 1 replication in macrophages and immature dendritic cells. J Virol. 2006; 80(12):6177-81. PMC: 1472578. DOI: 10.1128/JVI.02625-05. View

13.

Hessell A, Malherbe D, Haigwood N . Passive and active antibody studies in primates to inform HIV vaccines. Expert Rev Vaccines. 2018; 17(2):127-144. PMC: 6587971. DOI: 10.1080/14760584.2018.1425619. View

14.

Perez L, Costa M, Todd C, Haynes B, Montefiori D . Utilization of immunoglobulin G Fc receptors by human immunodeficiency virus type 1: a specific role for antibodies against the membrane-proximal external region of gp41. J Virol. 2009; 83(15):7397-410. PMC: 2708617. DOI: 10.1128/JVI.00656-09. View

15.

Hessell A, Rakasz E, Tehrani D, Huber M, Weisgrau K, Landucci G . Broadly neutralizing monoclonal antibodies 2F5 and 4E10 directed against the human immunodeficiency virus type 1 gp41 membrane-proximal external region protect against mucosal challenge by simian-human immunodeficiency virus SHIVBa-L. J Virol. 2009; 84(3):1302-13. PMC: 2812338. DOI: 10.1128/JVI.01272-09. View

16.

Pegu A, Yang Z, Boyington J, Wu L, Ko S, Schmidt S . Neutralizing antibodies to HIV-1 envelope protect more effectively in vivo than those to the CD4 receptor. Sci Transl Med. 2014; 6(243):243ra88. PMC: 4562469. DOI: 10.1126/scitranslmed.3008992. View

17.

Holl V, Hemmerter S, Burrer R, Schmidt S, Bohbot A, Aubertin A . Involvement of Fc gamma RI (CD64) in the mechanism of HIV-1 inhibition by polyclonal IgG purified from infected patients in cultured monocyte-derived macrophages. J Immunol. 2004; 173(10):6274-83. DOI: 10.4049/jimmunol.173.10.6274. View

18.

Huang Y, Yu J, Lanzi A, Yao X, Andrews C, Tsai L . Engineered Bispecific Antibodies with Exquisite HIV-1-Neutralizing Activity. Cell. 2016; 165(7):1621-1631. PMC: 4972332. DOI: 10.1016/j.cell.2016.05.024. View

19.

Perez L, Zolla-Pazner S, Montefiori D . Antibody-DEPENDENT, FcγRI-mediated neutralization of HIV-1 in TZM-bl cells occurs independently of phagocytosis. J Virol. 2013; 87(9):5287-90. PMC: 3624318. DOI: 10.1128/JVI.00278-13. View

20.

Groot F, Welsch S, Sattentau Q . Efficient HIV-1 transmission from macrophages to T cells across transient virological synapses. Blood. 2008; 111(9):4660-3. DOI: 10.1182/blood-2007-12-130070. View